Manspic Formulation Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 08-07-2024
- Paid Up Capital ₹ 0.20 M
as on 08-07-2024
- Company Age 12 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 16.27%
(FY 2023)
- Profit 139.89%
(FY 2023)
- Ebitda 424.60%
(FY 2023)
- Net Worth 13.47%
(FY 2023)
- Total Assets -0.15%
(FY 2023)
About Manspic Formulation
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Chanda Parwal, Pooja Lakhotiya, and Manish Lakhotiya serve as directors at the Company.
- CIN/LLPIN
U24232MP2012PTC027726
- Company No.
027726
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Feb 2012
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Gwalior, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Manspic Formulation Private Limited offer?
Manspic Formulation Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibacterial Drugs, Digestive System Drugs & Medicines, Antacid Drugs, Sexual Wellness Products, Contraceptives, Nutraceuticals & Dietary Supplements, Nutritional Supplements, Pain Relief Drugs & Pharmaceuticals, Diclofenac.
Who are the key members and board of directors at Manspic Formulation?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chanda Parwal  | Director | 13-Sep-2021 | Current |
| Pooja Lakhotiya | Director | 16-Jan-2018 | Current |
| Manish Lakhotiya | Director | 08-Nov-2021 | Current |
Financial Performance of Manspic Formulation.
Manspic Formulation Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.27% increase. The company also saw a substantial improvement in profitability, with a 139.89% increase in profit. The company's net worth Soared by an impressive increase of 13.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Manspic Formulation?
Unlock access to Manspic Formulation's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Kapic Lifesciences (Opc) Private LimitedActive 2 years 10 monthsManish Lakhotiya is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Manspic Formulation?
Unlock and access historical data on people associated with Manspic Formulation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Manspic Formulation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Manspic Formulation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
